V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90007819 | 90066628 | null | null | null | 2020-11-03 | 2020-11-03 | Topotecan (intravenous) | 02 | null | mEOC TRIAL | 101789868 |
| 60036563 | 60044324 | 1.74 | 59.5 | null | null | 2019-05-22 | Rituximab | 02 | null | ZICE TRIAL | 100003160 |
| 70081843 | 70114192 | 1.7 | 90.3 | Curative (C) | 2019-11-02 | 2019-11-03 | DECITABINE | 02 | null | ZANUBRUTINIB | 100131897 |
| 70081853 | 70114193 | 1.69 | 69 | null | null | 2020-03-08 | CYTARABINE + ETOPOSIDE + MITOXANTRONE | 02 | N | ZANUBRUTINIB | 101244105 |
| 70083281 | 70114219 | 1.58 | 59.2 | null | 2018-04-21 | 2018-04-21 | NHL 2003 Gp C M2 & 4 | 02 | null | ZANUBRUTINIB | 101161637 |
| 70096734 | 70114448 | null | 69 | null | 2016-07-25 | 2016-08-01 | BMT | 02 | N | ZANUBRUTINIB | 100552269 |
| 70094132 | 70163219 | 1.68 | 76.9 | null | 2019-01-03 | 2019-05-26 | MACE | 02 | null | ZANUBRUTINIB | 101165139 |
| 70102007 | 70200921 | 1.54 | 54.8 | null | 2020-03-12 | 2020-03-21 | null | 02 | null | ZANUBRUTINIB | 100404319 |
| 70045688 | 70185121 | null | 78.8 | Curative (C) | 2018-09-05 | 2018-12-18 | CARBOPLATIN + GEMCITABINE | 01 | N | ZANUBRUTINIB | 101764517 |
| 70092002 | 70176280 | 1.75 | 80.7 | Palliative (P) | 2017-10-23 | 2017-11-21 | GEMCITABINE + OXALIPLATIN + PEGASPARAGINASE | 02 | Y | ZANUBRUTINIB | 101684639 |
| 70088132 | 70176266 | 1.77 | 63 | null | 2021-09-28 | 2021-12-11 | EC | 02 | null | ZANUBRUTINIB | 100384990 |
| 70073936 | 70176191 | 1.61 | 44.1 | Curative (C) | null | 2018-06-05 | CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE | 02 | null | ZANUBRUTINIB | 101769764 |
| 70075582 | 70143486 | 1.81 | 90.6 | null | 2017-05-02 | 2017-05-10 | ALL Ph+ve Imatinib Cons HR3 PAsp | 99 | null | ZANUBRUTINIB | 101794690 |
| 70078008 | 70143525 | null | 17.6 | Curative (C) | 2019-02-04 | 2019-02-04 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PEGASPARAGINASE | 02 | null | ZANUBRUTINIB | 100813223 |
| 70103586 | 70143858 | 1.86 | 53 | Curative (C) | 2020-02-07 | 2020-02-29 | DAUNORUBICIN + METHOTREXATE + PEGASPARAGINASE + VINCRISTINE | N | N | ZANUBRUTINIB | 101017246 |
| 70085633 | 70143952 | 1.54 | 75.3 | null | 2020-04-24 | 2020-04-24 | DAUNORUBICIN | 02 | null | ZANUBRUTINIB | 100947882 |
| 10472514 | 10057791 | null | 70 | null | 2018-04-23 | 2018-04-24 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | null | ZANUBRUTINIB | 101726667 |
| 10426107 | 10057270 | 1.77 | 57.8 | null | 2019-09-09 | 2019-09-27 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | null | ZANUBRUTINIB | 100900217 |
| 10423155 | 10057222 | null | null | null | 2017-03-05 | 2018-02-28 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + VINCRISTINE | 02 | null | ZANUBRUTINIB | 101394410 |
| 60016619 | 60078440 | 1.72 | 81.7 | Palliative (P) | 2016-12-23 | 2017-05-22 | IPM | 01 | N | YTTRIUM-90 | 100399268 |
| 20139590 | 20087685 | 1.71 | 82.1 | Palliative (P) | null | 2019-11-16 | FCR Oral - Cycle 2 onwards | 01 | N | YTTRIUM-90 | 100410305 |
| 20051826 | 20086509 | 1.55 | null | Palliative (P) | 2019-04-29 | 2019-05-14 | GEM-P | 01 | N | YTTRIUM-90 | 101686745 |
| 70067247 | 70184983 | 0 | 76 | Curative (C) | 2019-07-01 | 2019-10-02 | ALL ALLR3: S/IR: Intens Wk 12-13 | 02 | N | Y-90 | 101763076 |
| 70048262 | 70162755 | 0 | 99.2 | Curative (C) | 2018-01-31 | 2019-05-04 | R GDP | 02 | N | Y-90 | 100967409 |
| 70062212 | 70143334 | 1.8 | 59.5 | null | 2019-05-06 | 2019-05-07 | ALL Interfant 06 Protocol 1B | 02 | null | Y-90 | 100272959 |
| 70049775 | 70184880 | 1.85 | 95 | Curative (C) | 2016-10-23 | 2019-05-15 | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 02 | N | Y-90 | 100624256 |
| 70062151 | 70143333 | 1.7 | 68.8 | Curative (C) | 2018-09-22 | 2018-09-22 | ALL Ph+ve Imatinib Continuation (maintenance) | 02 | N | Y-90 | 101397528 |
| 70054062 | 70190889 | 0 | 77.7 | null | 2021-04-13 | 2021-04-19 | NHL 2003 Gp B CYM 1 & 2 | 02 | null | Y-90 | 100925429 |
| 70053511 | 70197705 | 1.55 | 71 | null | 2018-05-10 | 2018-05-10 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | null | null | Y-90 | 100026171 |
| 70050938 | 70143098 | 0.81 | 90.6 | Curative (C) | 2021-12-18 | 2021-12-19 | TRANSPLANT ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | Y-90 | 100250345 |
| 70056512 | 70202725 | 1.68 | 88 | Curative (C) | 2022-04-20 | 2022-04-28 | SMILE | 01 | N | Y-90 | 100277005 |
| 40059166 | 40122877 | null | null | null | null | 2017-10-23 | Capecitabine + Trastuzumab | null | null | Y-90 | 100331151 |
| 70056004 | 70068636 | 1.77 | 15 | Curative (C) | 2019-06-24 | 2019-06-25 | CHOP R + METHOTREXATE | 99 | N | Y-90 | 100295236 |
| 70048510 | 70143041 | 0 | 86 | null | 2019-09-18 | 2019-10-21 | DARATUMUMAB + LENALIDOMIDE | 02 | N | Y-90 | 100525853 |
| 20129164 | 20134234 | 1.71 | 68 | Curative (C) | 2019-12-07 | 2019-12-07 | Capecitabine + Streptozocin | N | N | Y-90 | 101311392 |
| 120026076 | 120008477 | 0 | 0 | null | 2022-04-06 | 2022-04-20 | null | 02 | null | Y-90 | 101363706 |
| 70069020 | 70143395 | 0 | 11.5 | Disease modification (D) | null | 2018-10-16 | Cisplatin + Radiotherapy | 02 | N | Y-90 | 100724100 |
| 70060234 | 70113838 | 0 | 76 | Curative (C) | 2017-07-14 | 2017-07-14 | CARBOPLATIN + VINORELBINE | 02 | N | Y-90 | 100788693 |
| 70047287 | 70162739 | 0 | 74 | Curative (C) | 2016-03-22 | 2017-06-03 | FLAG | 02 | N | Y-90 | 100465319 |
| 70045305 | 70175951 | 0 | 83.3 | Curative (C) | 2017-04-20 | 2017-04-27 | Bortezomib + CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | 02 | N | Y-90 | 101169318 |
| 70057353 | 70143261 | 1.85 | 81.6 | null | 2020-10-24 | 2020-10-24 | ALL UKALL2003 TRIAL | 02 | null | Y-90 | 100359971 |
| 70054646 | 70162870 | 1.87 | 91.5 | null | 2019-11-15 | 2019-11-18 | ALL Interim Guide 2019 NOPHO B | 02 | null | Y-90 | 100687398 |
| 40084910 | 40123373 | 1.6 | 81.2 | null | 2017-09-20 | 2017-09-20 | EVEROLIMUS | 02 | null | Y-90 | 101611668 |
| 80052559 | 80047713 | 1.58 | 84.2 | null | 2021-01-01 | 2021-12-28 | null | null | null | WT2001 | 101071739 |
| 80063253 | 80036291 | 1.5 | 91 | Curative (C) | 2018-01-06 | 2018-04-14 | Capecitabine + Oxaliplatin 21day | 02 | N | WT2001 | 101855064 |
| 80014018 | 80022238 | null | null | Palliative (P) | 2017-07-30 | 2017-07-30 | null | N | null | WT2001 | 101118878 |
| 80008748 | 80022085 | null | null | null | 2019-05-09 | 2019-05-09 | null | 01 | N | WT2001 | 101312262 |
| 70084806 | 70163163 | 1.6 | 71 | null | 2018-01-21 | 2018-01-21 | BORTEZOMIB + CYTARABINE | 02 | null | WT1 TRIAL | 101288046 |
| 120022674 | 120013118 | null | null | null | null | 2018-03-03 | null | null | null | WT1 TRIAL | 101150475 |
| 80008120 | 80022067 | null | null | Palliative (P) | 2021-11-14 | 2021-11-28 | null | N | null | WT SIOP 2002 01 PRE OP VAV | 100840153 |